SARS-CoV-2	O
Enrichment	O
Sequencing	O
by	O
Spiked	O
Primer	O
MSSPE	O
method	O

Nasopharyngeal	O
and	O
oropharyngeal	O
swabs	O
(	O
combined	O
into	O
one	O
tube	O
)	O
were	O
collected	O
from	O
a	O
symptomatic	O
patient	O
meeting	O
case	O
definition	O
for	O
possible	O
infection	O
with	O
SARS-CoV-2	O
.	O

Extraction	O
of	O
viral	O
nucleic	O
acids	O
from	O
clinical	O
sample	O
was	O
performed	O
with	O
a	O
QIAamp	O
Viral	O
RNA	O
Mini	O
Kit	O
(	O
Qiagen	O
#	O
52906	O
)	O
as	O
described	O
by	O
manufacturer	O
Extracted	O
RNA	O
samples	O
were	O
DNAse-treated	O
using	O
the	O
Zymo	O
DNAse	O
I	O
kit	O
.	O

The	O
nucleic	O
acid	O
was	O
tested	O
via	O
real-time	O
polymerase	O
chain	O
reaction	O
for	O
COVID-19	O
using	O
both	O
the	O
Drosden	O
and	O
HKU	O
protocols	O
published	O
by	O
the	O
World	O
Health	O
Organization	O
and	O
confirmed	O
positive	O
for	O
COVID-19	O
on	O
January	O
27th	O
,	O
2020	O
.	O

Ct	O
values	O
for	O
PUI	O
=	O
24	O
.	O

RNA	O
was	O
quantified	O
using	O
the	O
Qubit	O
High	O
Sensitivity	O
RNA	O
kit	O
as	O
described	O
by	O
the	O
manufacturer	O
.	O

Qubit	O
input	O
RNA	O
concentration	O
for	O
PUI	O
=	O
6.9	O
ng/uL	O

Library	O
Preparation	O
was	O
performed	O
with	O
the	O
NEBNext	O
Ultra	O
II	O
non-directional	O
RNA	O
kit	O
.	O

Fragmentation	O
&	O
SARS-CoV-2	O
primer	O
spike	O
in	O
Random	O
primers	O
at	O
1	O
M	O
are	O
mixed	O
with	O
a	O
10	O
M	O
of	O
SARS-CoV-2	O
primers	O
(	O
see	O
below	O
)	O
at	O
a	O
1:1	O
volume	O
ratio	O
.	O

*	O
(	O
optional	O
)	O
ERCCs	O
are	O
internal	O
synthetic	O
RNA	O
controls	O
comprised	O
of	O
92	O
synthetic	O
RNAs	O
that	O
do	O
not	O
match	O
to	O
any	O
known	O
microbe	O
in	O
the	O
NCBI	O
NR/NT	O
databases	O
.	O

**	O
(	O
optional	O
)	O
FastSelect	O
is	O
designed	O
for	O
removing	O
human	O
rRNA	O
,	O
omit	O
this	O
reagent	O
if	O
not	O
using	O
human	O
derived	O
samples	O
and	O
only	O
incubate	O
at	O
94	O
C	O
and	O
then	O
directly	O
to	O
4	O
C	O
(	O
omit	O
ramping	O
down	O
steps	O
)	O
.	O

Thermocycler	O
(	O
heated	O
lid	O
set	O
to	O
105	O
C	O
)	O
:	O

8	O
min	O
at	O
94	O
C	O
(	O
Adjust	O
this	O
fragmentation	O
time	O
depending	O
on	O
the	O
quality	O
of	O
extracted	O
RNA	O
)	O

2	O
min	O
75	O
C2	O
min	O
70	O
C	O

2	O
min	O
65	O
C2	O
min	O
60	O
C	O

2	O
min	O
55	O
C5	O
min	O
37	O
C	O

5	O
min	O
25	O
C	O
8	O
min	O
at	O
94	O
C	O
(	O
Adjust	O
this	O
fragmentation	O
time	O
depending	O
on	O
the	O
quality	O
of	O
extracted	O
RNA	O
)	O

5	O
min	O
25	O
C	O

The	O
73	O
primers	O
tile	O
across	O
the	O
entire	O
SARS-CoV2	O
genome	O
at	O
a	O
spacing	O
of	O
~400bp	O
.	O

The	O
PDF	O
below	O
shows	O
the	O
approximate	O
location	O
of	O
the	O
primer	O
binding	O
sites	O
.	O

First	O
Strand	O
Synthesis	O
Mix	O
the	O
following	O
by	O
pipetting	O
up	O
and	O
down	O
.	O

10	O
mins	O
at	O
25	O
C	O

15	O
mins	O
at	O
42	O
C	O

15	O
mins	O
at	O
70	O
C	O

Hold	O
at	O
4	O
C	O
10	O
mins	O
at	O
25	O
C	O

Hold	O
at	O
4	O
C	O

Second	O
Strand	O
Synthesis	O
Thermocycler	O
(	O
heated	O
lid	O
off	O
)	O
:	O

1	O
hour	O
at	O
16	O
C	O

Hold	O
at	O
4	O
C	O

SPRI	O
cleanup	O

*allow	O
beads	O
to	O
sit	O
in	O
RT	O
for	O
30	O
mins	O
prior	O

Use	O
SPRI	O
Beads1.8x	O
ratio	O
of	O
beads-to-total	O
volume	O
of	O
sample	O
.	O

Prep	O
80	O
%	O
EtOH	O
.	O

Add	O
144uL	O
of	O
room	O
temperature	O
beads	O
to	O
2nd	O
Strand	O
Synthesis	O
Rxn	O
.	O

Mix	O
well	O
by	O
pipetting	O
gently	O
.	O

Pulse	O
spin	O
the	O
tubes	O
,	O
but	O
be	O
sure	O
not	O
to	O
spin	O
down	O
beads	O
.	O

Incubate	O
for	O
5	O
mins	O
at	O
room	O
temperature	O
.	O

Place	O
samples	O
on	O
magnetic	O
rack	O
,	O
and	O
incubate	O
for	O
5	O
mins	O
on	O
the	O
rack	O
.	O

Remove	O
supernatant	O
.	O

Add	O
200uL	O
of	O
80	O
%	O
EtOH	O
to	O
samples	O
while	O
on	O
the	O
magnetic	O
rack	O
.	O

Incubate	O
at	O
room	O
temperature	O
for	O
30s	O
then	O
remove	O
the	O
supernatant	O
.	O

Repeat	O
EtOH	O
wash	O
step	O
for	O
a	O
total	O
of	O
2	O
times	O

Air	O
dry	O
the	O
beads	O
for	O
5	O
mins	O
while	O
on	O
the	O
magnetic	O
rack	O
.	O

Remove	O
tube	O
from	O
magnetic	O
rack	O
.	O

Elute	O
DNA	O
from	O
beads	O
into	O
53uL	O
of	O
0.1x	O
TE	O
Buffer	O
,	O
10mM	O
Tris-HCl	O
,	O
or	O
Nuclease	O
free	O
water	O
.	O

Vortex	O
to	O
mix	O
.	O

Spin	O
tubes	O
and	O
incubate	O
for	O
2	O
mins	O
at	O
room	O
temperature	O
off	O
the	O
magnetic	O
rack	O
.	O

Place	O
on	O
magnetic	O
rack	O
until	O
solution	O
is	O
clear	O
~	O
5	O
mins	O
.	O

Remove	O
50uL	O
of	O
the	O
supernatant	O
and	O
transfer	O
to	O
a	O
clean	O
nuclease	O
free	O
PCR	O
tube	O
.	O

Use	O
SPRI	O
Beads	O

1.8x	O
ratio	O
of	O
beads-to-total	O
volume	O
of	O
sample	O
.	O

**Checkpoint	O
:	O
Samples	O
can	O
be	O
stored	O
frozen	O
at	O
-20	O
C	O
and	O
library	O
prep	O
resumed	O
the	O
next	O
day	O
.	O

End	O
Repair	O

Mix	O
all	O
the	O
following	O
by	O
pipetting	O
up	O
and	O
down	O

30	O
mins	O
at	O
20	O
C	O

30	O
mins	O
at	O
65	O
C	O

Adapter	O
Ligation	O

dilute	O
adaptor	O
to	O
dilution	O
prior	O
to	O
making	O
master	O
mix	O
.	O

Adaptor	O
concentration	O
depends	O
on	O
the	O
amount	O
of	O
input	O
;	O
1:100	O
dilution	O
for	O
samples	O
<	O
5ng	O
,	O
1:25	O
for	O
input	O
of	O
>	O
5ng	O

Add	O
adaptor	O
separately	O
after	O
ligation	O
master	O
mix	O
and	O
ligation	O
enhancer	O
to	O
avoid	O
adaptor	O
dimers	O
.	O

Thermocycler	O
(	O
heated	O
lid	O
off	O
)	O
:	O

15	O
mins	O
at	O
20	O
C	O
with	O
heated	O
lid	O
off	O

Proceed	O
immediately	O
to	O
Bead	O
Purification	O
.	O

15	O
mins	O
at	O
20	O
C	O
with	O
heated	O
lid	O
off	O

Proceed	O
immediately	O
to	O
Bead	O
Purification	O

Thermocycler	O
(	O
heated	O
lid	O
off	O
)	O
:	O

SPRI	O
Cleanup	O

*allow	O
beads	O
to	O
sit	O
in	O
RT	O
for	O
30	O
mins	O
prior	O

Use	O
SPRI	O
bead	O
0.9x	O
ratio	O
of	O
beads-to-total	O
volume	O
of	O
sample	O
.	O

Add	O
87uL	O
of	O
room	O
temperature	O
beads	O
(	O
0.9x	O
)	O
to	O
Adaptor	O
Ligation	O
reaction	O
.	O

Mix	O
well	O
.	O

Repeat	O
EtOH	O
wash	O
step	O
for	O
a	O
total	O
of	O
2	O
times	O
.	O

Air	O
dry	O
the	O
beads	O
for	O
5	O
mins	O
while	O
on	O
the	O
magnetic	O
rack	O
.	O

Elute	O
DNA	O
from	O
beads	O
into	O
17uL	O
of	O
0.1x	O
TE	O
Buffer	O
,	O
10mM	O
Tris-HCl	O
,	O
or	O
Nuclease	O
free	O
water	O
.	O

Remove	O
15uL	O
of	O
the	O
supernatant	O
and	O
transfer	O
to	O
a	O
clean	O
nuclease	O
free	O
PCR	O
tube	O
.	O

Use	O
SPRI	O
bead	O
0.9x	O
ratio	O
of	O
beads-to-total	O
volume	O
of	O
sample	O
.	O

Place	O
samples	O
on	O
magnetic	O
rack	O
,	O
and	O
incubate	O
for	O
5	O
mins	O
on	O
the	O
rack	O

Remove	O
supernatant	O
.	O

USER/Q5	O
Indexing	O
PCR	O
Mix	O
the	O
following	O
components	O
by	O
pipetting	O
up	O
and	O
down	O
.	O

Cycling	O
conditions	O
:	O
**	O
PCR	O
cycles	O
are	O
dependent	O
on	O
the	O
input	O
RNA	O
.	O

For	O
libraries	O
with	O
<	O
5ng	O
input	O
,	O
perform	O
15-19	O
cycles	O
of	O
PCR	O
.	O

For	O
5-20ng	O
input	O
,	O
perform	O
10-14	O
cycles	O
of	O
PCR	O
.	O

For	O
>	O
20ng	O
input	O
,	O
perform	O
6-8	O
cycles	O
of	O
PCR	O
.	O

*allow	O
beads	O
to	O
sit	O
in	O
RT	O
for	O
30	O
mins	O
prior	O

Use	O
SPRI	O
Beads	O
at	O
0.8x	O
ratio	O
of	O
beads-to-total	O
volume	O
of	O
sample	O
.	O

Add	O
43uL	O
of	O
room	O
temperature	O
Ampure	O
Beads	O
(	O
0.8x	O
)	O
to	O
barcoded	O
DNA	O
.	O

Elute	O
DNA	O
from	O
beads	O
into	O
23uLof	O
0.1x	O
TE	O
Buffer	O
,	O
10mMTris-HCL	O
,	O
or	O
Nuclease	O
free	O
water	O
.	O

Remove	O
20uL	O
of	O
the	O
supernatant	O
and	O
transfer	O
to	O
a	O
clean	O
nuclease	O
free	O
PCR	O
tube	O
.	O

Use	O
SPRI	O
Beads	O
at	O
0.8x	O
ratio	O
of	O
beads-to-total	O
volume	O
of	O
sample	O
.	O

**	O
Checkpoint	O
:	O
Libraries	O
are	O
complete	O
,	O
samples	O
can	O
be	O
stored	O
frozen	O
at	O
-20	O
C	O
until	O
ready	O
for	O
quantification	O
and	O
pooling	O
.	O

Libraries	O
were	O
quantified	O
by	O
the	O
Qubit	O
High	O
Sensitivity	O
DNA	O
kit	O
and	O
the	O
Agilent	O
High	O
Sensitivity	O
D500	O
DNA	O
Tapestation	O
assay	O
.	O

If	O
adapter	O
dimers	O
are	O
found	O
,	O
library	O
should	O
be	O
size	O
selected	O
using	O
a	O
SPRI	O
ratio	O
of	O
0.8x	O
.	O

Quantified	O
library	O
is	O
then	O
diluted	O
down	O
to	O
the	O
loading	O
concentration	O
for	O
the	O
iSeq	O
,	O
100pM	O
.	O

This	O
value	O
will	O
vary	O
depending	O
on	O
the	O
type	O
of	O
sequencer	O
.	O

The	O
Illumina	O
iSeq	O
was	O
loaded	O
with	O
20uL	O
of	O
a	O
100pM	O
library	O
with	O
a	O
5	O
%	O
PhiX	O
spike	O
in	O
.	O

Metagenomic	O
sequencing	O
results	O
were	O
uploaded	O
onto	O
IDseq.net	O
directly	O
from	O
the	O
Illumina	O
Basespace	O
Sequence	O
Hub	O
.	O

The	O
open-source	O
cloud-based	O
pipeline	O
analyzed	O
1.8	O
million	O
reads	O
.	O

The	O
majority	O
of	O
reads	O
mapped	O
to	O
the	O
nasal	O
and	O
oral	O
microbiome	O
.	O

Analyses	O
of	O
the	O
viral	O
components	O
resulted	O
in	O
3,077	O
single	O
end	O
reads	O
aligning	O
to	O
the	O
SARS-CoV2	O
taxon	O
.	O

Resulting	O
reads	O
from	O
the	O
Betacoronovirus	O
genus	O
were	O
downloaded	O
from	O
IDseq	O
and	O
mapped	O
to	O
the	O
NCBI	O
genome	O
accession	O
number	O
:	O
MN908947.1	O
.	O

The	O
geneious	O
alignment	O
displayed	O
even	O
coverage	O
across	O
the	O
genome	O
with	O
an	O
average	O
coverage	O
of	O
14.9x	O
.	O

One	O
SNP	O
was	O
noted	O
at	O
position	O
25,654	O
in	O
ORF3a	O
resulting	O
in	O
a	O
valine	O
to	O
leucine	O
substitution	O
when	O
compared	O
to	O
NCBI	O
accession	O
MN908947.1	O
.	O



